Literature DB >> 16001245

[HES 130 as a continuous supplement for organ culture of human corneas?].

C Redbrake1, S Kompa, G Altmann, M Reim, O Arend.   

Abstract

BACKGROUND: During organ culture, corneas swell and have to be de-swollen prior to transplantation using a medium. Both swelling and de-swelling lead to increased endothelial cell loss. Furthermore, dextran, the standard de-swelling substance, is toxic and deposited in the cornea. Whether HES is suitable as a continuous supplement for organ culture and keeps the corneas thin was investigated in this study.
METHODS: Forty-five human corneas were stored in MEM plus 7.5% HES 130 for 7, 15, 21, and 28 days. Endothelial cell count was determined before and after organ culture. After storage the water content and amount of adenosine phosphates were measured.
RESULTS: Water content was 82.29% after 7 days, 82.98% after 15 days, 81.15% after 21 days, and 83.21% after 28 days. The endothelial cell count decreased by 1.20% after 7 days, 0.60% after 15 days, 4.29% after 21 days, and 6.89% after 28 days. ATP was 0.159 micromol/g dry weight after 28 days of organ culture.
CONCLUSION: The water content of corneas stored in HES-containing medium remained constant even after 21 days of organ culture. Endothelial cell loss was less than in comparable studies using a standard medium containing 10% FCS; however, ATP concentrations were worse. HES 130 keeps the corneas thin and can be used as a continuous supplement. It facilitates the handling of corneas during organ culture, making dehydration before transplantation unnecessary, and thus also reduces potential stress factors for the cornea.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16001245     DOI: 10.1007/s00347-005-1236-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  8 in total

1.  MHC antigen presentation on the surface of hepatocytes: modulation during and after hypoxic stress.

Authors:  C F Eisenberger; R Viebahn; W Lauchart; H de Groot; H D Becker
Journal:  Transpl Int       Date:  1994       Impact factor: 3.782

2.  Employment of bioluminescence for the quantification of adenosine phosphates in the human cornea.

Authors:  S Salla; C Redbrake; A Frantz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

3.  Influence of colloid fluids on polymorphonuclear granulocyte function in vivo.

Authors:  J M Engel; I Welters; M Rupp; T Langefeld; R Ruwoldt; T Menges; G Hempelmann
Journal:  Acta Anaesthesiol Scand       Date:  2001-03       Impact factor: 2.105

4.  Persistent erythema and pruritus, with a confluent histiocytic skin infiltrate, following the use of a hydroxyethylstarch plasma expander.

Authors:  N H Cox; A W Popple
Journal:  Br J Dermatol       Date:  1996-02       Impact factor: 9.302

5.  A histochemical study of the distribution of dextran 500 in human corneas during organ culture.

Authors:  C Redbrake; S Salla; R Nilius; J Becker; M Reim
Journal:  Curr Eye Res       Date:  1997-05       Impact factor: 2.424

6.  [Hydroxyethyl starch for reversing edema in short-term culture media for donor corneas].

Authors:  M Hagenah; M Halberstadt; S Wehming; H Brewitt; R Winter
Journal:  Klin Monbl Augenheilkd       Date:  1996-02       Impact factor: 0.700

7.  Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery.

Authors:  Katrin Lang; Stefan Suttner; Joachim Boldt; Bernhard Kumle; Dietmar Nagel
Journal:  Can J Anaesth       Date:  2003-12       Impact factor: 5.063

8.  [Itching following therapy with hydroxyethyl starch (HES) in otoneurological diseases].

Authors:  K Albegger; R Schneeberger; V Franke; G Oberascher; K Miller
Journal:  Wien Med Wochenschr       Date:  1992
  8 in total
  1 in total

1.  Effect of different culture media and deswelling agents on survival of human corneal endothelial and epithelial cells in vitro.

Authors:  Monika Valtink; Patricia Donath; Katrin Engelmann; Lilla Knels
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-19       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.